CRISPR Editing Technology in Biological and Biomedical Investigation.

about

Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique.CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse.

P2860

Q38700979-E5C39B34-A19E-4AD1-9695-5A2EEBE6B82B Q55090892-EA50562B-2DC5-4018-88EB-D2548866C4A7 Q55364492-9793F0D4-6187-4F0F-A200-1074B30958C1

P2860

CRISPR Editing Technology in Biological and Biomedical Investigation.

Item

http://www.wikidata.org/entity/Q38688945

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

CRISPR Editing Technology in Biological and Biomedical Investigation.

@en

type

Item

label

CRISPR Editing Technology in Biological and Biomedical Investigation.

@en

prefLabel

CRISPR Editing Technology in Biological and Biomedical Investigation.

@en

P1476

CRISPR Editing Technology in Biological and Biomedical Investigation

@en

P2093

Martyn K White

http://www.w3.org/2001/XMLSchema#string

Pamela C Roehm

http://www.w3.org/2001/XMLSchema#string

Won-Bin Young

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems

Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

In Vivo Delivery Systems for Therapeutic Genome Editing

CRISPR/Cas9 and cancer targets: future possibilities and present challenges

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases

Using CRISPR/Cas to study gene function and model disease in vivo

CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells

Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will

P304

3586-3594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.26099

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Rafal Kaminski

Kamel Khalili

P577

2017-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28460414

http://www.w3.org/2001/XMLSchema#string

P921

CRISPR

P932

5682924

http://www.w3.org/2001/XMLSchema#string

CRISPR Editing Technology in Biological and Biomedical Investigation.

about

P2860

P2860

CRISPR Editing Technology in Biological and Biomedical Investigation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932